Adjuvant Intravesical Immunotherapy

Adjuvant intravesical immunotherapy is recognized as an effective treatment option for various urological cancer types. It plays a significant role in reducing the risk of recurrence, particularly in high-risk non-muscle-invasive bladder cancer cases. This treatment method is commonly utilized to diminish tumor residues following transurethral resection and prevent disease progression. Among the most frequently employed [...]